How to Play
We have made it easy for everyone to play RheumMadness. On Wednesday, Feb. 22, we will release all the scouting reports on the RheumMadness website, and the tournament will open for participants to submit their brackets. Participants will have four weeks to learn about the teams in the tournament and submit their picks. Bracket submissions will remain open through Wednesday, March 22. Submitting a bracket is free and easy; the process only takes a few minutes.
The results of the tournament will be released in five rounds, beginning Thursday, March 23, and continuing through Monday, April 3, at which time we will name the winners of RheumMadness 2023.
Connect with RheumMadness
Stay connected with RheumMadness to enjoy the learning and fun. Participants can sign up for our newsletter on our website, subscribe to the RheumMadness podcast (available on all major podcast applications) and join the conversation about RheumMadness on Twitter using the hashtag #RheumMadness.
We encourage fellowship programs and group practices to use RheumMadness material for their didactics and fill out their brackets together.
However you decide to engage with RheumMadness, we are sure you will have a fun and educational experience.
David L. Leverenz, MD, MEd, is an assistant professor of medicine in the Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, N.C.
Acknowledgments
The author thanks the following individuals for their contributions to this article and support for RheumMadness 2023: Courtney Bair, medical student, Duke University School of Medicine, Durham, N.C.; Meridith Balbach, medical student, Vanderbilt University School of Medicine, Nashville, Tenn.; Akrithi U. Garren, MD, assistant professor of medicine, Division of Rheumatology, MedStar Washington Hospital Center, Washington, D.C.; Lauren He, MD, chief internal medicine resident, University of Chicago; Guy Katz, MD, adult rheumatology fellow, Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Boston; Ben Kellogg, MD, internal medicine resident, Duke University Hospital; Benjamin D. Lueck, medical student, Duke University School of Medicine; Michael Macklin, MD, rheumatology fellow, Section of Rheumatology, University of Chicago; Iman Qaiser, MD, rheumatology fellow, Division of Rheumatology, Louisiana State University, Shreveport; Sabahat Usmani, MD, internal medicine resident, Weiss Memorial Hospital, Chicago; Matthew A. Sparks, MD, associate professor of medicine, Division of Nephrology, Duke University School of Medicine, and staff physician, Durham Veterans Affairs Health Care System, North Carolina; and Lisa G. Criscione-Schreiber MD, MEd, professor of medicine, Division of Rheumatology and Immunology, Duke University School of Medicine, and staff physician, Durham Veterans Affairs Health Care System.
